G. Vadlamani

发表

Pre-surgical mapping of eloquent cortex for paediatric epilepsy surgery candidates: Evidence from a review of advanced functional neuroimaging

Arshad Zaman, John Goodden, Garreth Prendergast, 2017, Seizure.

GNAO1 encephalopathy

N. Mahant, E. Valente, F. Raymond, 2017, Neurology: Genetics.

Monitoring the changing pattern of delivery of paediatric epilepsy surgery in England—an audit of a regional service and examination of national trends

P. Chumas, C. Ferrie, G. Vadlamani, 2015, Child's Nervous System.

Novel Missense CNTNAP2 Variant Identified in Two Consanguineous Pakistani Families With Developmental Delay, Epilepsy, Intellectual Disability, and Aggressive Behavior

D. Cutler, P. Chopra, M. Zwick, 2022, Frontiers in Neurology.

GNAO1 encephalopathy Broadening the phenotype and evaluating treatment and outcome

N. Mahant, E. Valente, F. Raymond, 2022 .

Assessing evidence quality in research reporting neurocognitive outcomes following paediatric temporal lobe surgery for epilepsy

M. Waterman, P. Chumas, Poppy Siddell, 2019, Epilepsy Research.

Neuropsychological outcomes following paediatric temporal lobe surgery for epilepsies: Evidence from a systematic review

M. Waterman, P. Chumas, G. Vadlamani, 2017, Seizure.

Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms.

C. Ferrie, G. Vadlamani, J. Cross, 2015, The Cochrane database of systematic reviews.

Cerebral hypomyelination associated with biallelic variants of FIG4

P. Lockhart, A. Vanderver, M. Meisler, 2019, Human mutation.

Clinical and radiological characterization of novel FIG4‐related combined system disease with neuropathy

I. Simonic, Soo-Mi Park, R. Horvath, 2020, Clinical genetics.

Cystic Leukoencephalopathy due to NDUFV1 mutation—A Report of the Phenotype and Its Rare Co-occurrence with Primary Hyperoxaluria

Robert W. Taylor, C. Alston, G. Vadlamani, 2016, Journal of Pediatric Neurology.

Genetic and phenotypic spectrum associated with IFIH1 gain-of-function

A. Vanderver, Y. Crow, D. Lev, 2020, Human mutation.

5% Carbon Dioxide is safe but of limited efficacy as a treatment for paediatric non-convulsive status epilepticus: An open label observational study.

R. Forsyth, M. Lai, T. Martland, 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.